Comparison of CBV, BEAM and BEAC high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation in non-Hodgkin lymphoma: Efficacy and toxicity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison of CBV, BEAM and BEAC high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation in non-Hodgkin lymphoma: Efficacy and toxicity

Published:2017-01-19 Issue:5 Volume:13 Page:e423-e429
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia-Pac J Clin Oncol

Author:

Shi Youwu¹,Liu Peng¹,Zhou Shengyu¹,Yang Jianliang¹,Han Xiaohong¹,He Xiaohui¹,Zhang Changgong¹,Gui Lin¹,Qin Yan¹,Yang Sheng¹,Zhao Liya¹,Yao Jiarui¹,Jia Bo¹,Zhang Shuxiang¹,Sun Yan¹,Shi Yuankai¹

Affiliation:

1. Department of Medical Oncology; Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs; National Cancer Center / Cancer Hospital; Chinese Academy of Medical Sciences & Peking Union Medical College; Beijing China

Funder

National Science-Technology Support Plan Projects

National Technologies Research and Development Program of China during the 9th Five-Year Plan Period

Ministry of Education Doctor Foundation of China

Ying Dong Fok Foundation for Young College Teacher

Publisher

Wiley

Subject

Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajco.12610/fullpdf

Reference24 articles.

1. Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era;Gisselbrecht;J Clin Oncol,2010

2. Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma;Stiff;N Engl J Med,2013

3. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma;Philip;N Engl J Med,1995

4. Advancement in high dose therapy and autologous stem cell rescue in lymphoma;Isidori;World J Stem Cells,2015

5. Study of conditioning regimens with or without high-dose radiotherapy before autologous stem cell transplantation for treating aggressive lymphoma;Niu;Int J Hematol,2009

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fotemustine, etoposide, cytarabine, and cyclophosphamide (FEAC) conditioning regimen for autologous stem cell transplantation in lymphoma;Leukemia & Lymphoma;2023-01-19

2. Novel conditioning regimen in upfront autologous stem cell transplantation in high-risk DLBCL;Bone Marrow Transplantation;2022-07-25

3. Efficacy and toxicity of SEAM (semustine, etoposide, cytarabine, and melphalan) conditioning regimen followed by autologous stem cell transplantation in lymphoma;Hematology;2022-04-12

4. A gemcitabine-based regimen followed by autologous stem cell transplantation show high efficacy and well tolerance in malignant lymphoma;Bone Marrow Transplantation;2022-04-07

5. Outcome of CBV (Carmustine, Cyclophosphamide, Etoposide) Conditioning Regimen for Autologous Stem Cell Transplant in Lymphoma: A Retrospective Study from a Tertiary Cancer Center in South India;Indian Journal of Medical and Paediatric Oncology;2022-02-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3